Deepankar Roy | Senior Director, Investor Relations |
Joseph Payne | President and Chief Executive Officer |
Andrew Sassine | Chief Financial Officer |
Pad Chivukula | Chief Scientific Officer and Chief Operating Officer |
Yasmeen Rahimi | Piper Sandler |
Evan Wang | Guggenheim Partners |
Nick Abbott | Wells Fargo Securities |
Yigal Nochomovitz | Citigroup |
Kumaraguru Raja | Brookline Capital Markets |
Steven Seedhouse | Raymond James & Associates |
Thomas Yip | H.C. Wainwright & Co. |
Good day. And welcome to the Arcturus Therapeutics First Quarter 2022 Earnings Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Deepankar Roy, Senior Director of Investor Relations. Please go ahead, sir.